Advanced Search

Share

Home Most often read

Pulmonology

Pulmonology

ISSN: 2531-0437

Pulmonology (previously Revista Portuguesa de Pneumologia) is the official journal of the Portuguese Society of Pulmonology (Sociedade Portuguesa de Pneumologia/SPP). The journal publishes 6 issues per year, mainly about respiratory system diseases in adults and clinical research. This work can range from peer-reviewed original articles to review articles, editorials, and opinion articles. The journal is printed in English, and is freely available in its web page as well as in Medline and other databases.

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

See more

Pulmonology has ceased to be published by Elsevier and is now published by Taylor & Francis available here.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2023

10.4

View more metrics

Journal Information

Most often read

Vol. 30. Issue. 6

20296

Impact of the 2022 ATS/ERS update criteria on the bronchodilator responsiveness test result

B. Martins, A. Marinho, P. Amorim

Pulmonol. 2024;30:673-4

20296

Full text access

Share

17197

Unraveling the resurgence of pertussis: Insights into epidemiology and global health strategies

Minzhong Wan, Guobin Zhang, Hang Yi

Pulmonol. 2024;30:503-5

17197

Full text access

Share

13606

Recommendations for the implementation of a national lung cancer screening program in Portugal—A consensus statement

M.G.O. Fernandes, M. Dias, R. Santos, S. Ravara, P. Fernandes, J. Firmino-Machado, J.P. Antunes, O. Fernandes, ... A. Morais

Pulmonol. 2024;30:625-35

13606

Full text access

Share

12166

Pre- and post-COVID practice of interventional pulmonology in adults in Portugal

F. Guedes, A.J. Ferreira, J. Dionísio, L.V. Rodrigues, A. Bugalho

Pulmonol. 2024;30:537-45

12166

Full text access

Share

11848

Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up

F. Pistelli, D.L. Sherrill, F. Di Pede, S. Baldacci, M. Simoni, S. Maio, L. Carrozzi, G. Viegi

Pulmonol. 2024;30:546-54

11848

Full text access

Share

11669

Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries

G. Sarno, I. Stanisci, S. Maio, S. Williams, E.M. Khoo, S.G. Diaz, E.V. Ponte, L.T.T. Lan, ... G. Viegi

Pulmonol. 2024;30:595-624

11669

Full text access

Share

10372

Predictors of lung entrapment in malignant pleural effusion

R. Trovisco, C. Freitas, M. Serino, P. Ferreira, B. Martins, D. Coelho, N. Melo, G. Fernandes, ... H.N. Bastos

Pulmonol. 2024;30:555-62

10372

Full text access

Share

10094

The Brompton breathing pattern assessment tool (BPAT): Portuguese translation and cultural adaptation

R. Vilarinho, C. Ribeiro, V. Abreu, S. Souto-Miranda, F. Silva, C. Jácome

Pulmonol. 2024;30:646-7

10094

Full text access

Share

9949

Prone position for acute respiratory distress syndrome and the hazards of meta-analysis

D. Poole, A. Pisa, R. Fumagalli

Pulmonol. 2024;30:529-36

9949

Full text access

Share

9704

Chronic obstructive pulmonary disease exacerbations' management in Portuguese hospitals – EvaluateCOPDpt, a multicentre, observational, prospective study

J. Moita, U. Brito, C. Rodrigues, L. Ferreira, J.R. Vieira, A. Catarino, A. Morais, V. Hespanhol, C.R. Cordeiro

Pulmonol. 2024;30:522-8

9704

Full text access

Share

9478

What do we know about macrolides immunomodulatory therapeutic potential in respiratory disease in 2023

Daniela Godinho, Marta Freixa, Filipe Froes

Pulmonol. 2024;30:509-11

9478

Full text access

Share

9458

Reliability and validity of the Chester step test in patients with interstitial lung disease

A. Alves, A. Oliveira, P.G. Ferreira, V. Martins, A. Marques

Pulmonol. 2024;30:570-6

9458

Full text access

Share

9384

Associations and relative risks of pulmonary hypertension and lung diseases in individuals with methamphetamine use disorder

S.C. Fang, C.Y. Huang, S.M. Huang, Y.J. Shao

Pulmonol. 2024;30:577-85

9384

Full text access

Share

8429

Evaluation of maximal exercise capacity through the incremental shuttle walking test in lymphangioleiomyomatosis

D. Silva Queiroz, C.C.B. Marques da Silva, A. Franco Amaral, M. Rodrigues Oliveira, J.M. Salge, C.R. Ribeiro Carvalho, B. Guedes Baldi, C.R.F. Carvalho

Pulmonol. 2024;30:563-9

8429

Full text access

Share

7883

Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients

C.A. Amado, M. García-Unzueta, J. Agüero, P. Martín-Audera, P. Fueyo, B.A. Lavín, A.R. Guerra, P. Muñoz, ... C. Casanova

Pulmonol. 2024;30:512-21

7883

Full text access

Share

7701

Profile of emergency department overuse in hospitalized patients with pulmonary disease and its impact on mortality

J. Barbosa, D. Organista, T. Rodrigues, A.F. Matos, A. Barardo, A. Escoval, C. Bárbara, F. Rodrigues

Pulmonol. 2024;30:586-94

7701

Full text access

Share

7595

Obstructive Sleep Apnoea (OSA) and early atherosclerosis: The role of microbiota and EVs

D.M. Toraldo, P. Piscitelli, F. De Nuccio

Pulmonol. 2024;30:506-8

7595

Full text access

Share

7298

Chronic cough in patients with obstructive sleep apnoea: A prospective cohort study

Laurent Guilleminault, Jérémie Riou, Sandrine Pontier, Kamila Sedkaoui, Frédéric Gagnadoux, Wojciech Trzepizur

Pulmonol. 2024;30:659-62

7298

Full text access

Share

6864

Intensity of exercise in people with COPD enrolled in community-based physical activities

P. Rebelo, A. Teixeira, R. Pinto, C. Santos, D. Brooks, A. Marques

Pulmonol. 2024;30:642-5

6864

Full text access

Share

6844

Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis

R. Hindré, V. Besnard, F. Kort, H. Nunes, D. Valeyre, F. Jeny

Pulmonol. 2024;30:639-41

6844

Full text access

Share

Pulmonology